Harman Patil (Editor)

Metabolic alkalosis

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Specialty
  
Endocrinology

ICD-9-CM
  
276.3

eMedicine
  
med/1459

ICD-10
  
E87.3

DiseasesDB
  
402

Metabolic alkalosis

Metabolic alkalosis is a metabolic condition in which the pH of tissue is elevated beyond the normal range (7.35-7.45). This is the result of decreased hydrogen ion concentration, leading to increased bicarbonate, or alternatively a direct result of increased bicarbonate concentrations.

Contents

Terminology

  • Alkalosis refers to a process by which the pH is increased.
  • Alkalemia refers to a pH which is higher than normal, specifically in the blood.
  • Causes

    The causes of metabolic alkalosis can be divided into two categories, depending upon urine chloride levels.

    Chloride-responsive (Urine chloride < 10 mEq/L)

  • Loss of hydrogen ions - Most often occurs via two mechanisms, either vomiting or via the kidney.
  • Vomiting results in the loss of hydrochloric acid (hydrogen and chloride ions) with the stomach contents. In the hospital setting this can commonly occur from nasogastric suction tubes.
  • Severe vomiting also causes loss of potassium (hypokalaemia) and sodium (hyponatremia). The kidneys compensate for these losses by retaining sodium in the collecting ducts at the expense of hydrogen ions (sparing sodium/potassium pumps to prevent further loss of potassium), leading to metabolic alkalosis.
  • Congenital chloride diarrhea - rare for being a diarrhea that causes alkalosis instead of acidosis.
  • Contraction alkalosis - This results from a loss of water in the extracellular space, such as from dehydration. Decreased extracellular volume triggers the renin-angiotensin-aldosterone system, and aldosterone subsequently stimulates reabsorption of sodium (and thus water) within the nephron of the kidney. However, a second action of aldosterone is to stimulate renal excretion of hydrogen ions (while retaining bicarbonate), and it is this loss of hydrogen ions that raises the blood pH.
  • Diuretic therapy - loop diuretics and thiazides can both initially cause increase in chloride, but once stores are depleted, urine excretion will be below < 25 mEq/L. The loss of fluid from sodium excretion causes a contraction alkalosis.
  • Posthypercapnia - Hypoventilation (decreased respiratory rate) causes hypercapnia (increased levels of CO2), which results in respiratory acidosis. Renal compensation with excess bicarbonate occurs to lessen the effect of the acidosis. Once carbon dioxide levels return to base line, the higher bicarbonate levels reveal themselves putting the patient into metabolic alkalosis.
  • Cystic Fibrosis
  • Chloride-resistant (Urine chloride > 20 mEq/L)

  • Retention of bicarbonate - retention of bicarbonate would lead to alkalosis
  • Shift of hydrogen ions into intracellular space - Seen in hypokalemia. Due to a low extracellular potassium concentration, potassium shifts out of the cells. In order to maintain electrical neutrality, hydrogen shifts into the cells, raising blood pH.
  • Alkalotic agents - Alkalotic agents, such as bicarbonate (administrated in cases of peptic ulcer or hyperacidity) or antacids, administered in excess can lead to an alkalosis.
  • Hyperaldosteronism - Renal loss of hydrogen ions occurs when excess aldosterone (Conn's syndrome) increases the activity of a sodium-hydrogen exchange protein in the kidney. This increases the retention of sodium ions whilst pumping hydrogen ions into the renal tubule. Excess sodium increases extracellular volume and the loss of hydrogen ions creates a metabolic alkalosis. Later, the kidney responds through the aldosterone escape to excrete sodium and chloride in urine.
  • Excess Glycyrrhizin consumption
  • Bartter syndrome and Gitelman syndrome - syndromes with presentations analogous to taking diuretics characterized with normotensive patients
  • Liddle syndrome - a gain of function mutation in the genes encoding the epithelial sodium channel (ENaC) which is characterized by hypertension and hypoaldosteronism.
  • 11β-hydroxylase deficiency and 17α-hydroxylase deficiency - both characterized by hypertension
  • Aminoglycoside toxicity can induce a hypokalemic metabolic alkalosis via activating the calcium sensing receptor in the thick ascending limb of the nephron, inactivating the NKCC2 cotransporter, creating a Bartter's syndrome like effect.
  • Compensation

    Compensation for metabolic alkalosis occurs mainly in the lungs, which retain carbon dioxide (CO2) through slower breathing, or hypoventilation (respiratory compensation). CO2 is then consumed toward the formation of the carbonic acid intermediate, thus decreasing pH. Respiratory compensation, though, is incomplete. The decrease in [H+] suppresses the peripheral chemoreceptors, which are sensitive to pH. But, because respiration slows, there's an increase in pCO2 which would cause an offset of the depression because of the action of the central chemoreceptors which are sensitive to the partial pressure of CO2 in the cerebral spinal fluid. So, because of the central chemoreceptors, respiration rate would be increased.

    Renal compensation for metabolic alkalosis, less effective than respiratory compensation, consists of increased excretion of HCO3 (bicarbonate), as the filtered load of HCO3 exceeds the ability of the renal tubule to reabsorb it.

    To calculate the expected pCO2 in the setting of metabolic alkalosis, the following equations are used:

  • pCO2 = 0.7 [HCO3] + 20 mmHg +/- 5
  • pCO2 = 0.7 [HCO3] + 21 mmHg
  • References

    Metabolic alkalosis Wikipedia